Efficacy and safety of Chinese medicine in treating risk window of AECOPD: A multicenter randomized controlled trial
Treatment of AECOPDRW with CM showed high efficacy and safety in significantly reducing further incidences of acute exacerbation, prolonging the interval to the initial acute exacerbation, alleviating the clinical symptoms, and improving the quality of life.
Authors
- Huanrong Ruan (ORCID: https://orcid.org/0000-0002-5215-1471)
- Congxia Hou
- Hailang He (ORCID: https://orcid.org/0000-0002-7798-500X)
- Xinyi Liu (ORCID: https://orcid.org/0009-0000-4160-4482)
- Ya Li (ORCID: https://orcid.org/0000-0003-4356-7042)
- Hailong Zhang (ORCID: https://orcid.org/0000-0003-3316-4290)
- Jiansheng Li (ORCID: https://orcid.org/0000-0002-6485-2371)
- Guixiang Zhao (ORCID: https://orcid.org/0009-0007-0022-584X)
- S.S. Hou
- Weixu Sun
Institutions
- Zhumadian Central Hospital (CN)
- Luoyang Central Hospital Affiliated to Zhengzhou University (CN)
- Henan Provincial Chest Hospital (CN)
- Jiangsu Province Hospital (CN)
- First Affiliated Hospital of Henan University (CN)
- Luoyang Orthopedic-Traumatological Hospital of Henan Province (CN)
- Anyang Hospital of Traditional Chinese Medicine (CN)
- Luoyang Institute of Science and Technology (CN)
Publication Details
- Journal
- Phytomedicine
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1016/j.phymed.2025.156903
- Citations
- 1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52